Discovering New Ginger Compounds with Enhanced Anti-Inflammatory Benefits

Jim Crocker
14th July, 2024

Discovering New Ginger Compounds with Enhanced Anti-Inflammatory Benefits

Ginger plant (Zingiber officinale)

Photo adapted from: Vincent A. Vos / CC BY (Source)

Key Findings

  • Researchers at the National University of Tainan, Taiwan, developed a method to improve the solubility of gingerols using an enzyme called α-glucosidase
  • The enzyme glycosylated gingerols into three distinct mono-glucosides, significantly enhancing their solubility and stability
  • The glycosylated gingerols showed improved anti-inflammatory activity, with one compound exhibiting a ten-fold increase compared to the original gingerol
Ginger, derived from the rhizomes of Zingiber officinale, has been used for centuries in traditional medicine for its numerous health benefits. The primary bioactive compounds in ginger, known as gingerols, have been extensively studied for their medicinal properties, including anti-inflammatory, antioxidant, and anticancer activities[2][3][4]. However, a significant limitation of gingerols is their low aqueous solubility, which restricts their effectiveness in medical applications. A recent study by researchers at the National University of Tainan, Taiwan, has addressed this issue by developing a method to improve the solubility of gingerols and enhance their pharmacological properties[1]. The study focused on using an enzyme called α-glucosidase from Agrobacterium radiobacter DSM 30147 (ArG) to glycosylate gingerols, thereby producing novel glucosides. Glycosylation is a process where a sugar molecule is attached to another molecule, which can significantly improve solubility and stability. The researchers successfully subcloned, expressed, and purified ArG, confirming that it possessed additional α-glycosyltransferase activity, an enzyme function that facilitates the transfer of sugar moieties to specific substrates. Through optimization, the researchers were able to glycosylate gingerols into three distinct mono-glucosides, with varying yields: 63.0% for compound 1, 26.9% for compound 2, and 4.37% for compound 3. The optimization process involved adjusting the conditions to 50 mM phosphate buffer (pH 6) with 50% (w/v) maltose and 1000 mM Li+ at 40°C over a 24-hour incubation period. This meticulous optimization was crucial for maximizing the production yield of the gingerol glucosides. The structures of the purified glucosides were determined using nuclear magnetic resonance (NMR) and mass spectral analyses. Compound 1 was identified as 6-gingerol-5-O-α-glucoside, and compound 2 was a novel compound, 8-gingerol-5-O-α-glucoside. These structural modifications significantly improved the aqueous solubility of gingerols, which is a critical factor for their bioavailability and therapeutic efficacy. One of the most notable findings of the study was the enhanced anti-inflammatory activity of the glycosylated gingerols. The 6-gingerol-5-O-α-glucoside exhibited a ten-fold increase in anti-inflammatory activity compared to the original 6-gingerol, with an IC50 value of 15.3 ± 0.5 μM. The novel 8-gingerol-5-O-α-glucoside retained 42.7% of the anti-inflammatory activity of 8-gingerol, with an IC50 value of 106 ± 4 μM. These results suggest that glycosylation not only improves solubility but can also enhance or retain the biological activity of gingerols. The study builds on previous research demonstrating the wide range of biological activities of gingerols and shogaols, including their roles in alleviating nausea, arthritis, and various forms of pain[3]. The findings also align with earlier studies that highlighted the immunomodulatory properties of gingerols, which are attributed to their ability to inhibit key inflammatory signaling pathways[4]. By improving the solubility and bioavailability of gingerols, this research paves the way for more effective therapeutic applications. In conclusion, the study conducted by the National University of Tainan represents a significant advancement in the biomedical application of gingerols. By employing an α-glucosidase enzyme to glycosylate gingerols, the researchers have successfully enhanced their solubility and anti-inflammatory activity. This innovative approach not only addresses the solubility issue but also opens new avenues for the development of gingerol-based clinical drugs, particularly for inflammation-related conditions. The findings underscore the potential of gingerols as valuable therapeutic agents and highlight the importance of continued research in this area.

MedicineBiochemSpices

References

Main Study

1) Exploring gingerol glucosides with enhanced anti-inflammatory activity through a newly identified α-glucosidase (ArG) from Agrobacterium radiobacter DSM 30147.

Published 11th July, 2024

https://doi.org/10.1016/j.jbiosc.2024.06.004

Related Studies

2) Revisiting the therapeutic potential of gingerols against different pharmacological activities.

https://doi.org/10.1007/s00210-022-02372-7

3) Gingerols and shogaols: Important nutraceutical principles from ginger.

https://doi.org/10.1016/j.phytochem.2015.07.012

4) Immunomodulatory and anti-inflammatory therapeutic potential of gingerols and their nanoformulations.

https://doi.org/10.3389/fphar.2022.902551


Related Articles

An unhandled error has occurred. Reload 🗙